Martine Rothblatt

2020

In 2020, Martine Rothblatt earned a total compensation of $4.8M as Chairperson and Chief Executive Officer at United Therapeutics, a 89% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,575,757
Non-Equity Incentive Plan$1,873,080
Salary$1,352,435
Other$10,400
Total$4,811,672

Rothblatt received $1.9M in non-equity incentive plan, accounting for 39% of the total pay in 2020.

Rothblatt also received $1.6M of change in pension value and nonqualified deferred compensation earnings, $1.4M in salary and $10.4K in other compensation.

Rankings

In 2020, Martine Rothblatt's compensation ranked 2,313th out of 13,090 executives tracked by ExecPay. In other words, Rothblatt earned more than 82.3% of executives.

ClassificationRankingPercentile
All
2,313
out of 13,090
82nd
Division
Manufacturing
888
out of 5,618
84th
Major group
Chemicals And Allied Products
318
out of 2,251
86th
Industry group
Drugs
269
out of 1,951
86th
Industry
Pharmaceutical Preparations
193
out of 1,456
87th
Source: SEC filing on April 29, 2022.

Rothblatt's colleagues

We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2020.

2020

Michael Benkowitz

United Therapeutics

Chief Operating Officer

2020

Paul Mahon

United Therapeutics

General Counsel

2020

James Edgemond

United Therapeutics

Chief Financial Officer

News

You may also like